Peer-reviewedLicence not statedJAMA Dermatology
Ixekizumab With or Without Tirzepatide in Adults With Psoriasis and Overweight or Obesity
11 affiliations
- 1Department of Dermatology, Icahn School of Medicine at Mount Sinai, New York, New York
- 2Blauvelt Consulting, LLC, Annapolis, Maryland
- 3Eli Lilly and Company, Indianapolis, Indiana
- 4Department of Dermatology, Medical College of Wisconsin, Milwaukee
- 5School of Cardiovascular and Metabolic Health, University of Glasgow, Glasgow, Scotland
- 6Department of Dermatology, Hospital de la Santa Creu i Sant Pau, Universitat Autònoma de Barcelona School of Medicine, Barcelona, Spain
- 7Department of Dermatology and Department of Medicine, Division of Rheumatology, UT Southwestern Medical Center and O’Donnell School of Public Health, Dallas, Texas
- 8Syneos Health, Morrisville, North Carolina
- 9Division of Dermatology, University of California Los Angeles David Geffen School of Medicine, Los Angeles
- 10Central Connecticut Dermatology Research, Cromwell
- 11Department of Dermatology, Yale University School of Medicine, New Haven, Connecticut
Related
- Urban exposome and sleep and overweight/obesity outcomes in European adolescents
- Case Report: GADA-positive type 1 diabetes with diabetic ketoacidosis in a young adult with obesity temporally associated with unsupervised tirzepatide use for weight reduction
- Semaglutide in Patients with Obesity and Psoriasis: Insights from an 18-Month Real-World Experience
- Effects of exercise interventions on leptin and ghrelin levels in middle-aged and older adults with overweight or obesity: a systematic review and meta-analysis
- Metabolic health and cardiovascular risk among Cameroonian adults with and without obesity
BibTeX
@article{lebwohl2026ixekizumab,
title = {{Ixekizumab With or Without Tirzepatide in Adults With Psoriasis and Overweight or Obesity}},
author = {Mark Lebwohl and Andrew Blauvelt and Cynthia E. Kartman and Cianna Leatherwood and Kenneth B. Gordon and Naveed A. Sattar and L. Puig and Joseph Frank Merola and Kimberly Siu and Rona Wang and Luna Sun and Ann Leung and Najwa Somani and María José Rueda and Anabela Cardoso and Mark C. Genovese and April W. Armstrong and Bruce E Strober},
journal = {JAMA Dermatology},
year = {2026},
month = may,
doi = {10.1001/jamadermatol.2026.1753},
url = {https://pubmed.ncbi.nlm.nih.gov/42139049/},
}
RIS
TY - JOUR
TI - Ixekizumab With or Without Tirzepatide in Adults With Psoriasis and Overweight or Obesity
AU - Mark Lebwohl
AU - Andrew Blauvelt
AU - Cynthia E. Kartman
AU - Cianna Leatherwood
AU - Kenneth B. Gordon
AU - Naveed A. Sattar
AU - L. Puig
AU - Joseph Frank Merola
AU - Kimberly Siu
AU - Rona Wang
AU - Luna Sun
AU - Ann Leung
AU - Najwa Somani
AU - María José Rueda
AU - Anabela Cardoso
AU - Mark C. Genovese
AU - April W. Armstrong
AU - Bruce E Strober
PY - 2026
DA - 2026/05/15
JO - JAMA Dermatology
DO - 10.1001/jamadermatol.2026.1753
UR - https://pubmed.ncbi.nlm.nih.gov/42139049/
SN - 2168-6068
SN - 2168-6084
ER -